Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Atherosclerosis. 2007 Aug 9;196(2):624–632. doi: 10.1016/j.atherosclerosis.2007.06.024

Figure 4.

Figure 4

Effects of native LDL (nLDL) on CD34+ cell AT1 receptor (AT1R) expression (upper panel) and AT1R-mediated myeloproliferation (lower panel). A neutralizing LDL receptor antibody (LDLRab) or nonspecific IgG (n-IgG) was added in some experiments. Each condition represents triplicate experiments from each monkey. The data represent the mean ± SEM of 6 experiments. *P < 0.05, compared to LPDS. **P < 0.05, compared to vehicle.